| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |